A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -26.36% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -26.76%. Over the past 30 days, the price of BDSX has leaped by -11.44%. And in the last five days, it has fallen by -5.24%.
Biodesix Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $2.21 on 02/05/24, while the lowest value for the same period was recorded at $1.03 on 07/27/23.
52-week price history of BDSX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Biodesix Inc’s current trading price is -38.69% away from its 52-week high, while its distance from the 52-week low is 31.55%. The stock’s price range during this period has varied between$1.03 and $2.21. The Biodesix Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.43 million for the day, a figure considerably higher than their average daily volume of 0.11 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Biodesix Inc (BDSX) has experienced a quarterly decline of -31.57% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 131.35M and boasts a workforce of 217 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.6416, with a change in price of +0.1200. Similarly, Biodesix Inc recorded 115,375 in trading volume during the last 100 days, posting a change of +9.64%.
BDSX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BDSX stands at 13.25. Similarly, the long-term debt-to-equity ratio is also 13.19.
BDSX Stock Stochastic Average
Biodesix Inc’s raw stochastic average for the past 50 days is presently 12.89%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 40.32%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 69.36% and 70.71%, respectively.
